Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Journal of Clinical & Experimental OncologyISSN: 2324-9110
Erika Mejia Hidalgo Author
Subjects of specialization
Affiliation
Mucoepidermoid carcinoma, Cancer chemotherapy, Prostate biomarker, Endometrial cancer
Former basic science research volunteer at Molecular Oncology Research Institute, Tufts Medical Center, Boston, MA, USA
Biography
Erika Mejia Hidalgo was working as a Former basic science research volunteer at Molecular Oncology Research Institute, Tufts Medical Center, Boston, MA, USA. He has more than 40 publications. His current research area related to osteoarthropathy.
Publications
Research Article Subscription
Lack of Association between Angiogenin (AGN) KO Mice with Improvement in Muscle Strength, Resistance,but Decreased in Chances of Tumorigenesis: Observational Study
Author(s): Mariuxi Viteri Malone, Erika Mejia Hidalgo and Guofu Hu
Background: For quite a while, there has been controversy over whether or not angiogenin is associated with amyotrophic lateral sclerosis (ALS) risk. A lot of meta-analysis has been done in the last few years to support the fact that angiogenin has no relationship in improving the outcome and muscle strength in ALS. In the other hand, for about 3 decades angiogenin has been thought to play an important role in cell survival, growth, and proliferation. Evidence suggests that the expression and activity of ANG increases the odds of developing a variety of human cancers. We present the results of an observational study done in wild type (WT) and angiogenin knock out (ANG -/- KO) mice in order to determine phenotype and different features as exp... view more»
Google Scholars / Researchers Sites
